Paul Tudor Jones Charles River Laboratories International, Inc. Transaction History

Tudor Investment Corp Et Al

$26.8 Billion
Q3 2024

A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 1,300 shares of CRL stock, worth $241,540. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,300

Previous 18,998 93.16%

Holding current value

$241,540

Previous $3.92 Million 93.48%

% of portfolio

0.0%

Previous 0.02%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$206.39 - $268.73 $350,243 - $456,034	-1,697 Reduced 8.2%	18,998 $3.92 Million
Q1 2024 May 15, 2024	SELL	$203.52 - $273.43 $9.2 Million - $12.4 Million	-45,222 Reduced 68.6%	20,695 $5.61 Million
Q4 2023 Feb 14, 2024	BUY	$164.52 - $238.84 $1.44 Million - $2.09 Million	8,744 Added 15.29%	65,917 $15.6 Million
Q3 2023 Nov 15, 2023	BUY	$194.44 - $217.61 $11.1 Million - $12.4 Million	57,173 New	57,173 $11.2 Million
Q2 2022 Aug 15, 2022	BUY	$204.13 - $302.4 $760,792 - $1.13 Million	3,727 Added 29.9%	16,193 $3.47 Million
Q1 2022 May 16, 2022	BUY	$255.51 - $362.11 $274,673 - $389,268	1,075 Added 9.44%	12,466 $3.54 Million
Q4 2021 Feb 14, 2022	BUY	$351.38 - $448.68 $4 Million - $5.11 Million	11,391 New	11,391 $4.29 Million
Q3 2021 Nov 15, 2021	SELL	$372.64 - $458.3 $1.26 Million - $1.54 Million	-3,368 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$294.17 - $371.65 $3.06 Million - $3.87 Million	-10,418 Reduced 75.57%	3,368 $1.25 Million
Q1 2021 May 17, 2021	BUY	$249.67 - $299.48 $1.23 Million - $1.48 Million	4,934 Added 55.74%	13,786 $4 Million
Q4 2020 Feb 16, 2021	BUY	$222.0 - $252.62 $1.97 Million - $2.24 Million	8,852 New	8,852 $2.21 Million
Q2 2020 Aug 14, 2020	SELL	$118.84 - $189.72 $424,496 - $677,679	-3,572 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$98.9 - $178.34 $103,350 - $186,365	1,045 Added 41.35%	3,572 $451,000
Q4 2019 Feb 14, 2020	SELL	$126.05 - $152.76 $335,671 - $406,799	-2,663 Reduced 51.31%	2,527 $386,000
Q3 2019 Nov 14, 2019	BUY	$125.07 - $143.67 $649,113 - $745,647	5,190 New	5,190 $687,000

Others Institutions Holding CRL

# of Institutions

695

Shares Held

52.2M

Call Options Held

259K

Put Options Held

463K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.45B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track Paul Tudor Jones's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Account